Congenica Selected to Provide Diagnostic Decision Support for UK’s Genomic Medicine Service
Genomics England names Congenica as its clinical decision support service partner for the delivery of the NHS genomic medicine service.
Read MorePosted by Steve Halasey | Nov 28, 2018 | Cancer |
Genomics England names Congenica as its clinical decision support service partner for the delivery of the NHS genomic medicine service.
Read MorePosted by Steve Halasey | Nov 15, 2018 | Disease States, Infectious Diseases, Molecular Diagnostics, Sexually Transmitted Diseases |
Advanced testing methods promise improved patient outcomes and better protection of public health—with potential cost savings.
Read MorePosted by Steve Halasey | Nov 14, 2018 | Immunoassay, Research |
The new test is a high-sensitivity, high-precision, single-test solution for the diagnosis of true Clostridioides difficile infection.
Read MorePosted by Steve Halasey | Nov 13, 2018 | Cancer, Molecular Diagnostics, Research |
The test challenges a $100 million annual US laboratory market by reducing costs through a simple, screening assay.
Read MorePosted by Steve Halasey | Nov 13, 2018 | Molecular Diagnostics |
The new molecular diagnostic enables the direct detection of varicella-zoster virus DNA from cerebrospinal fluid.
Read More